Lv1
30 积分 2022-04-20 加入
Ritanserin as add-on medication to neuroleptic therapy for patients with chronic or subchronic schizophrenia
2天前
已完结
Predicting new molecular targets for known drugs
12天前
已完结
Genotoxicity of 2-(3-Chlorobenzyloxy)-6-(piperazinyl)pyrazine, a Novel 5-Hydroxytryptamine2c Receptor Agonist for the Treatment of Obesity: Role of Metabolic Activation
13天前
已完结
A proposed new nomenclature for 5-HT receptors
15天前
已完结
Molecular Characterization of a Functional cDNA Encoding the Serotonin 1c Receptor
15天前
已完结
Flexible scaffold-based cheminformatics approach for polypharmacological drug design
15天前
已完结
Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006
1个月前
已关闭
The MCPP challenge test in schizophrenia: Hormonal and behavioral responses
1个月前
已完结
261. Metformin and 5-HT2C Agonist Lorcaserin for Weight Loss in Schizophrenia
1个月前
已完结
Rare chromosomal deletions and duplications increase risk of schizophrenia
1个月前
已完结
皖公网安备34019202002308
